Lexaria Bioscience Corp.

New Filing
CIK: 0001348362·Biotechnology·NEVADA·Filed: Sep 18, 2026
Total Offering

$113,492

Amount Sold

$113,492

Investors

3

First Sale

Sep 9, 2026

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Christopher Bunka
John Docherty
Richard Christopher
Michael Shankman
Nicholas Baxter
William Edward McKechnie
ALBERT REESE
Bal Bhullar

Company

Lexaria Bioscience Corp.

100 - 740 MCCURDY ROAD

KELOWNA, A1, V1X 2P7

250-765-6424

SEC Filing

0001348362-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free